YourSpine.com - Chiropractic - Arthritis Drug Remicade Raises Risk For Lymphoma

Arthritis Drug Remicade Raises Risk For Lymphoma

The Associated Press reported on October 7, 2004 that the maker of the arthritis drug Remicade sent out a letter warning doctors that patients taking the drug developed the cancer lymphoma at a rate three times higher than the general public.

The company, Centocor, is a subsidiary of Johnson & Johnson, headquartered in Malvern, Pennsylvania. Working with the U.S. Food and Drug Administration (FDA), Centocor revised the label of Remicade to reflect the lymphoma risk.

It was the second label change the company has had to make for Remicade in the last six weeks. In August of 2004 the company warned that people taking Remicade for rheumatoid arthritis and Crohn’s disease can experience fatal central nervous system and blood disorders.

Change Zip Code Close